Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Citigroup Inc. 

Integra LifeSciences Holdings Corp diskutieren

Integra LifeSciences Holdings Corp

WKN: 897013 / Symbol: IART / Name: Integra / Aktie / Ausrüstung & Versorgung / Mid Cap /

26,40 €
0,76 %

Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.
Ratings data for IART provided by MarketBeat

Einschätzung Sell
Rendite (%) -28,26 %
Kursziel 39,84
Veränderung
Endet am 24.05.24

Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $43.00 price target on the stock, down previously from $56.00.
Ratings data for IART provided by MarketBeat

Einschätzung Sell
Rendite (%) -21,43 %
Kursziel 35,14
Veränderung
Endet am 26.10.24

Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $44.00 to $37.00. They now have an "underweight" rating on the stock.
Ratings data for IART provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,11 %
Kursziel 46,23
Veränderung
Endet am 14.11.24

Integra LifeSciences Holdings Co. (NASDAQ: IART) is now covered by analysts at CL King. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for IART provided by MarketBeat

Einschätzung Buy
Rendite (%) -28,57 %
Kursziel 45,24
Veränderung
Endet am 05.12.24

Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $49.00 price target on the stock, up previously from $40.00.
Ratings data for IART provided by MarketBeat

Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IART provided by MarketBeat